Besson JM - Search Results

1

Selective disruption of DNMT1/ELK1 interactions induces DGKI re-expression and promotes temozolomide sensitivity of MGMT^methylated/DGKI^methylated glioblastoma.

Besson JM, Etcheverry A, Nadaradjane A, Bougras-Cartron G, Aubry M, Frenel JS, Chevanieu A, Lopez M, Mosser J, Cartron PF. Besson JM, et al. Clin Epigenetics. 2025 Aug 30;17(1):146. doi: 10.1186/s13148-025-01943-8. Clin Epigenetics. 2025. PMID: 40886022 Free PMC article.

2

Gisèle Guilbaud (1936-2013).

Besson JM. Besson JM. Eur J Pain. 2014 May;18(5):599-600. doi: 10.1002/j.1532-2149.2014.00482.x. Eur J Pain. 2014. PMID: 24737542 No abstract available.

3

Severe cerebral white matter hyperintensities predict severe cognitive decline in patients with cerebrovascular disease history.

Dufouil C, Godin O, Chalmers J, Coskun O, MacMahon S, Tzourio-Mazoyer N, Bousser MG, Anderson C, Mazoyer B, Tzourio C; PROGRESS MRI Substudy Investigators. Dufouil C, et al. Stroke. 2009 Jun;40(6):2219-21. doi: 10.1161/STROKEAHA.108.540633. Epub 2009 Apr 23. Stroke. 2009. PMID: 19390070 Clinical Trial.

4

Parturition in the rat: a physiological pain model.

Catheline G, Touquet B, Besson JM, Lombard MC. Catheline G, et al. Among authors: besson jm. Anesthesiology. 2006 Jun;104(6):1257-65. doi: 10.1097/00000542-200606000-00022. Anesthesiology. 2006. PMID: 16732098

5

Effects of the high-efficacy 5-HT1A receptor agonist, F 13640 in the formalin pain model: a c-Fos study.

Buritova J, Larrue S, Aliaga M, Besson JM, Colpaert F. Buritova J, et al. Among authors: besson jm. Eur J Pharmacol. 2005 May 9;514(2-3):121-30. doi: 10.1016/j.ejphar.2005.03.016. Eur J Pharmacol. 2005. PMID: 15910798

6

Density measurements of liquid under high pressure and high temperature.

Katayama Y, Tsuji K, Shimomura O, Kikegawa T, Mezouar M, Martinez-Garcia D, Besson JM, Häusermann D, Hanfland M. Katayama Y, et al. Among authors: besson jm. J Synchrotron Radiat. 1998 May 1;5(Pt 3):1023-5. doi: 10.1107/S0909049597015239. Epub 1998 May 1. J Synchrotron Radiat. 1998. PMID: 15263732

7

Morphine withdrawal precipitated by specific mu, delta or kappa opioid receptor antagonists: a c-Fos protein study in the rat central nervous system.

Le Guen S, Gestreau C, Besson JM. Le Guen S, et al. Among authors: besson jm. Eur J Neurosci. 2003 Jun;17(11):2425-37. doi: 10.1046/j.1460-9568.2003.02678.x. Eur J Neurosci. 2003. PMID: 12814374

8

The novel analgesic and high-efficacy 5-HT1A receptor agonist, F 13640 induces c-Fos protein expression in spinal cord dorsal horn neurons.

Buritova J, Tarayre JP, Besson JM, Colpaert F. Buritova J, et al. Among authors: besson jm. Brain Res. 2003 Jun 6;974(1-2):212-21. doi: 10.1016/s0006-8993(03)02582-4. Brain Res. 2003. PMID: 12742639

9

Antinociceptive effects of RB101(S), a complete inhibitor of enkephalin-catabolizing enzymes, are enhanced by (+)-HA966, a functional NMDA receptor antagonist: a c-Fos study in the rat spinal cord.

Buritova J, Le Guen S, Fournié-Zaluski MC, Roques BP, Besson JM. Buritova J, et al. Among authors: besson jm. Eur J Pain. 2003;7(3):241-9. doi: 10.1016/S1090-3801(02)00122-2. Eur J Pain. 2003. PMID: 12725847

10

Further evidence for the interaction of mu- and delta-opioid receptors in the antinociceptive effects of the dual inhibitor of enkephalin catabolism, RB101(S). A spinal c-Fos protein study in the rat under carrageenin inflammation.

Le Guen S, Catheline G, Fournié-Zaluski MC, Roques BP, Besson JM, Buritova J. Le Guen S, et al. Among authors: besson jm. Brain Res. 2003 Mar 28;967(1-2):106-12. doi: 10.1016/s0006-8993(02)04231-2. Brain Res. 2003. PMID: 12650971

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

317 results

Search Page

Filters